Both thyroxine (T 4 ) and triiodothyronine (T]) are carried in serum bound to protein, mainly by the specific thyroxine-binding globulin (TBG) and to a lesser extent by prealbumin and albumin. The concentrations of these binding proteins and their avidities for T 4 and T] differ widely (Table 1) ; a dynamic equilibrium exists in the serum between free and bound fractions, maintained by the production and clearance rates of the respective hormones and the binding characteristics of the proteins (Fig. 1) . The avidity of the proteins is so high that the concentrations of serum free hormones are minute, of the order of 20 pmol/L for T 4 and 5 pmol/L for T 3 . 1 Since virtually all the hormone is bound, total concentrations will closely follow changes in binding protein levels (especially TBG). The view is widely held that the free moiety alone may enter the cell and produce the appropriate effect, and that the thyroidal status of an individual is determined by the concentration of free rather than total hormone. This concept receives strong support from the undeniable euthyroid state of subjects with very high or very low TBG concentrations associated with similarly altered total thyroid hormone levels, yet in whom measurements of free hormone remain normal (vide infra). Recently, however, these traditional views have been questioned/: 3 and it has been suggested that the binding proteins playa more active role in the delivery of thyroid hormone to the tissues This paper was prepared at the invitation of the Clinical Laboratory Investigations Working Party of the Scientific Committee of the Associationof Clinical Biochemists, but does not necessarily reflect their views. TABLE 1. Thyroid hormone-binding proteins in serum rather than a passive carrier function. While providing a ready focus for stimulating debate, the concept of selective delivery of thyroid hormones to different tissues remains to be explored. It is especially relevant to the proposition that the pituitary resembles all other tissues and that therefore pituitary TSH secretion is an absolutely reliable guide to thyroid hormone availability.
In many laboratories, the notion that free rather than total thyroid' hormone measurements provide a more accurate reflection of tissue hormone availability has been accepted for many years, and the 'routine' thyroid function test offered has been the total T4 by radioimmunoassay combined with some means of correction for the binding protein levels, usually in the form of a Tj-uptake test. The combination of these two tests allows an indirect assessment of the free T 4 concentration in the form of the 'free thyroxine index'. 4 Until recently the direct measurement of free thyroid hormones in serum was confined to a small number of research laboratories using the laborious technique of equilibrium dialysis, a procedure totally unsuitable for routine work. However, over the last 5 years there has been considerable progress in the development of In this brief article we outline the theoretical basis of these new assays, their performance in various clinical situations and the problems posed in their interpretation in some unusual circumstances.
Methodology
A novel solution to the problem of free hormone radioimmunoassay was provided by Midgley and Wilkins 5 who conceived, and successfully produced, a radioimmunoassay which could directly produce a measure of free T 4 concentrations. These authors deserve credit for the courage to break one of the holy tenets of radioimmunoassay; viz. that the tracer must resemble the analyte as closely as possible. The principle of the new free hormone radioimmuno assays requires as radioactive tracer a thyroid hormone molecule which has been chemically modified to prevent its binding to the serum transport proteins, whilst not affecting its ability to bind to the reagent antibody. In this aim they have been very successful and the affinity of the analogue tracer for TBG and prealbumin, the major carrier proteins, has been reduced to negligible levels, i.e. to about 3% of the binding strength of T/ whilst the affinit1' for albumin is approximately 10% that of T 4 • As no compound, such as 8-aniIinonaphthalene sulphonic acid, is added to the system to displace T 4 from binding proteins, the tracer competes with free T 4 only for binding to the reagent antibody; binding of this tracer to reagent antibody is then inversely related to free hormone concentrations. For convenience at the separation stage, the reagent antibody is attached to a solid phase and, as required by the principles of isotope dilution methodology, only a small quantity of antibody is used and a high avidity ensures a speedy assay. Only a small proportion of the total T4 is sampled by the antibody and the equilibrium distribution of T 4 in serum is not significantly disturbed."
The success of this technique is clear from its rapid and widespread adoption and the speedy launching of similar kits by other commercial companies. Most employ a reagent antibody attached to a solid phase of some kind (e.g. magnetic particle or the test tube surface)
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together with an analogue of T 4 as tracer. It is not known, at least to these authors, whether the same or similar analogue tracers are used in the various kits; certainly the antibodies vary.
Quite hard on the heels of these assays came the development of similar methods for free T] estimations. The latter are not so widely used but, as will be seen, do have a useful role. The Arnerlex" kits are the most widely used in the UK and the majority of published work relates to experience with these. Except where interference with the kit's working is directly related to the properties of tracer and antibody (which may vary), there is no reason to expect substantial differences amongst the different kits.
Applications

HYPERTHYROIDISM
In thyrotoxicosis both total serum T 4 and T] are usually raised, but in "Tj-toxicosis' total T 4 is normal and total T] elevated. This entity has perhaps attracted attention out of proportion to its importance; in the UK it is very rare in Graves' disease and more often seen in patients with nodular goitre. The situation is further complicated by a sub-group of asymptomatic patients in whom total hormone levels are within the reference range but show biochemical evidence of thyroid overactivity, e.g. a failure of TSH to rise after administration of TRH. Whether this implies genuine hyperthyroidism is a contentious issue; some have used the term subclinical hyperthyroidism to describe this group and advocate vigorous treatment on the grounds that adverse cardiovascular complications (for example, atrial fibrillation) may be prevented."
Generally, both free T 4 and free T] are raised in concert with the total hormone levels; it has been suggested that free T] might provide a more accurate discrimination of the hyperthyroid state than any other single thyroid hormone assay.!'' This assertion is based on a theoretical consideration of the changes in free and total T 4 and T] in vitro when hormonal input is increased, and may be somewhat artificial in that no account is taken of the increased hormone clearance in vivo in hyperthyroidism. However, the available data fail to show a clear advantage of free T] over free T 4 measurements in thyrotoxicosis; in 36 hyper-thyroid patients both parameters were elevated;'! whereas Mahlstedt'? reported 21 out of 333 cases in whom free T 3 was normal and 29 of the same group had normal free T4 results.
The free hormone assays are probably superior to total hormone estimations in the diagnosis of hyperthyroidism, if only because they remove the confusion caused by high concentrations of binding proteins (particularly TBG) in total hormone assays, but there seems little to choose between the free T4 and the free T 3; there will always be difficult cases in whom several thyroid function tests are required in combination with a careful clinical assessment before the diagnosis is established.
More recently, new techniques have been developed which allow the measurement of low TSH concentrations with far greater sensitivity than was previously possible in routine laboratory practice. It has been suggested that a single TSH estimation will readily distinguish the very low or undetectable levels found in hyperthyroidism from those found in euthyroid subjects, thus removing the need for the TRH test. There is evidence that discrimination between euthyroid and thyrotoxic subjects is indeed provided by these assaysl3 but more data is required before their place in routine thyroid function testing is defined clearly.
HYPOTHYROIDISM
The diagnosis of obvious clinical myxoedema is rarely difficult and the biochemical findings are characteristic. Total serum T4 falls before total T 3, possibly due to an increase in T 3 secretion by the thyroid under TSH stimulation, and/or an increase in the peripheral conversion of T4 to T 3 . The major problem is the detection of less marked degrees of hypothyroidism, particularly the contentious issue of subclinical hypothyroidism or compensated euthyroidism, terms used to describe individuals in whom total thyroid hormone levels are within the reference range for the normal population, while TSH concentrations are elevated. In these circumstances measurement of free hormones is likewise unhelpful. 47 out of 148 (32%) of patients clinically classified as hypothyroid had free T] concentrations within the normal range' while the free T 4 was subnormal in 84%. Total T 3 , well recognised as a poor discriminant in hypothyroidism, was normal in 43% while total T 4 gave the correct classification in 72%.
It might appear, therefore, that free T 4 is the investigation of choice in hypothyroidism, but unfortunately this is often normal when TSH concentration is raised. Whether this latter implies a hypothyroid state is still debated; the available data show that TSH is often elevated in the presence of quite 'normal' free T 4 results.
In an unselected series of 60 sera in which TSH concentration was abnormally high, the free T 4 was normal in 32 (53%).14 These latter cases were patients with auto-immune thyroid disease and those on treatment for hypothyroidism with thyroxine. The difficulty of the so-called subclinical hypothyroid patient therefore remains whether total or free hormone measurements are employed. The introduction of the highly sensitive TSH assays will not resolve this problem.
NON-THYROIDAL ILLNESS (NTI)
The literature on free thyroid hormones in NTI is both confused and contentious. This is, at least in part, related to the wide spectrum of disease type and severity included under this one banner and is one consequence of the ease with which the modern clinician may obtain 'thyroid function tests'. A great number of tests are performed in patients for whom thyroid disease is not a serious diagnostic consideration. The referring physician justifies this practice on the grounds that thyroid disease may present atypically, particularly in the elderly, and being eminently treatable should be sought with vigour in the form of a barrage of tests. III health of any description affects both the transport and the metabolism of thyroid hormones in a complex manner. 15 The synthesis and serum levels of the binding proteins may fall with corresponding reduction in total T 4 and T 3 concentrations. In addition, the extrathyroidal conversion of T 4 to T 3 is diminished, leading to the 'low-T, syndrome', a term used to describe the sick patient with low T 3 and normal TSH levels. Whether this represents tissue hypothyroidism or an adaptation to illness, as occurs during starvation, remains unclear.
Free thyroid hormone determinations in NTI show that free T 3 , like total T 3 , is often low and to exclude hypothyroidism a TSl-{ assay is necessary. Conversely, the free T 4 is a more robust parameter and tends to remain within the reference range in the majority of cases. 16 It is the firm opinion of the authors that indiscriminate requests for thyroid function in patients clearly ill from non-thyroidal disease is a practice that should be severely deprecated.
Little benefit accrues to either patient or physician from the knowledge that total or free T] concentrations are low. In the context of the severely ill, this finding is no more than a confirmation of what is patently clear from the end of the bed. Thyroid function tests in the sick patient are rarely, if ever, helpful in immediate patient management. Indeed, the circumstances where thyroid disease poses an immediate threat to life (thyroid storm and myxoedema coma) are diagnosed on clinical grounds and treatment should be instituted before the results of the hormone measurements are known.
THYROXINE REPLACEMENT
In health the thyroid gland secretes both T 4 and T], but the major contribution to the latter's daily production rate is via the peripheral metabolism of T 4 . l 7 If the thyroid gland is absent as a result of disease, surgery or radioiodine and if thyroxine replacement is given, then the patient is entirely dependent on the extrathyroidal conversion of T 4 for T] production. Because thyroidal input of T] is absent it may be necessary to achieve higher serum T 4 levels than 'normal' to provide an adequate level of T]. A significant proportion of healthy patients stabilised on long-term replacement therapy for hypothyroidism have both total and free T 4 concentrations above the normal range. In a -third of such patients both free and total T 4 were elevated, while total and free T] remained normal in the great majority. IN It was suggested that the finding of an elevated total or free T 4 did not necessarily imply over-treatment, and that a more helpful investigation would be the demonstration of a normal free T] in the presence of an adequately suppressed TSH concentration, the latter representing adequacy of replacement. In this series the same information was derived from the total serum T, as none of these subjects had an abnormal TBG concentration.
PREGNANCY
The increasing oestrogen levels during pregnancy cause a corresponding rise in TBG synthesis and serum levels. However, total T4 and T J do not rise to the same extent, and one theory 19 predicts a consequent fall in free T 4 and free T, levels towards the end of pregnancy. Measurements of free hormones during pregnancy using quite different methodologies confirm this. The mean values for both analytes are reduced and some values fall beneath the Free thyroid hormone assays 233 normal range by the third trimester. Similarly, free T4 is also reduced in male patients receiving large doses of oestrogen for prostatic cancer." The reason for this is not established but modified occupancy of nuclear receptors for T 3 has been proposedr" No degree of hypothyroidism has been suggested. Separate normal ranges for third trimester samples will be necessary but TSH estimations may also be required. The free thyroxine index does not fall in late pregnancy; this is artefactual because the T,-uptake methods fail as TBG rises to high levels and thus fortuitously correct for the proportionately lesser rise in T4 concentrations.P Free hormone concentrations are normal in women taking oestrogen-containing oral contraceptives. Although their TBG levels may be raised in response to the oestrogens, the doses given-particularly in the modern formulations-r-are presumably too low to affect receptor numbers.
DRUG INTERFERENCE
Compounds causing changes in TBG concentrations are associated with parallel alterations in total T 4 and T" while the free hormone levels remain normal. Drugs such as phenylbutazone and aspirin which compete with thyroid hormones for binding to TBG produce lowered total serum hormone concentrations; free hormone assays are usually within the reference range, although there may be a small reduction.P The non-steroidal anti-inflammatory agent fenclofenac is one of the most effective known displacers of T4 from TBG. In two studies using different techniques the level of free T4 was reduced." 25 In the latter work free T] was also slightly lower as measured by equilibrium dialysis. Difficulties can arise if patients are given intravenous heparin; this activates lipoprotein lipase which continues to be active after the blood has been taken and raises the level of endogenous free fatty acids in the sample.P In vitro these disturb the binding of thyroid hormones and their analogues and thus produce artefactually low results.
The anti-anginal agent amiodarone has a complex action on thyroid hormone metabolism. Both hyper-and hypothyroidism have been reported with its use, probably due to the liberation of large amounts of iodine released in the course of the drug's metabolism. In addition, there is inhibition of the peripheral 5' -deiodination mechanism and total serum T, falls. Unlike most other drugs which produce this 'low T 3 syndrome', amiodarone may cause an increase in TSH secretion and hyperthyroxinaemia. Free T 4 concentrations are also raised and there is a small but significant fall in free T 3.
27 If the question of thyrotoxicosis arises in a patient receiving amiodarone the most helpful tests are probably the total and free T 3 and the TSH responses to TRH.
ABNORMAL THYROID HORMONE
TRANSPORT
Even the best of technologies may fail in the face of situations for which it was not designed. A potential for perturbing analogue-tracer assays exists in sera containing either unusual concentrations of the binding proteins or unusual binding proteins. In fact, such interference occurs much less often than might be feared. Extreme variations in TBG concentration are without influence.": 2X similarly, variations in prealbumin and albumin in healthy controls within the normal range are without effect.r" In the very rare condition of analbuminaemia lower values than expected are found for free T 4 ,29 . 3D but this has been corrected with a recent reformulation of one commercial kit 3 ! to include blockade of residual binding of tracer to albumin. In vitro studies, in which large amounts of albumin (> 25 gIL) were added to serum, have suggested a minor influence of this protein on determined values.Y: 33 but this has been obviated for normal circumstances by the inclusion of blockers as mentioned above. The lack of influence of the concentration of transport proteins is to be expected since the analogue tracers have been selected for that behaviour.
The greatest potential for interference comes from the presence of abnormal transport proteins, i.e. those molecular variants of albumin, prealbumin and TBG with altered affinities for thyroid hormones, and that subset of autoantibodies against thyroglobulin which bind thyroid hormones. Even in these circumstances, interference is not always seen. Sera from euthyroid subjects who have the variant prealbumins with increased affinity for Tl4 or the variant TBGs with decreased affinity for T 4 and T 3 35 have mildly elevated or reduced levels of total T4 respectively, but give entirely reasonable results in the free hormone assays (Table 2) .
There are three distinct variants of albumirr": 37 with increased avidities for thyroid hormones which are associated with raised levels of these compounds ( Table 2 ). The Tj-uptake test, which effectively measures spare capacity of thyroid hormone binding proteins, is normal in these sera and the calculated FTI is therefore raised. Types I and II cause erroneously high values with free T 4 assays due to tracer binding to the variant but free T 3 values are normal. For type III both tests give falsely high results. The subjects are clinically euthyroid with a normal basal TSH and response of TSH to TRH and equilibrium dialysis gives normal results for free hormones. Thus, there is a characteristic biochemical profile (Table 2 ) which, for a euthyroid subject, is probably sufficient to identify the presence of such a protein. It can be confirmed by reverseflow electrophoresis" or by the Ts-uptake procedure.Y: 39 The variant albumins are not common although their true prevalence is unknown. We have found two families in our area and examples are being identified throughout Britain. The abnormal prealbumins may be more common; we have detected five subjects with these variants within our own catchment area (population ca. 200 (JOO). Their thyroid function test results are borderline (Table 2) and many may be missed on total Tz-based schemes of investigation and will not be identified when free hormone assays are used. We have identified one family in whom both albumin and prealbumin variants are present. Molecular variants of TBG with reduced avidity for T 4 and T] are very common in certain ethnic groups. Approximately 25% of Australian aboriginals are affected'" and about 5% of East African Asians resident in NW London." Sporadic occurrence in Europeans has also been noted; we have identified two such families from our own practice.
Interference with free hormone assays from autoantibodies which bind thyroid hormones is variable and unpredictable and results in raised values due to sequestration of tracer. However, in some cases, reasonable results may be obtained in the presence of these immunoglobulins.P' 41 and this seems to relate to the specificity of the antibodies/" i.e. a Ta-specific antibody may have little or no reaction with the T 4 analogue and thus not interfere with free T 4 assays; similarly, Tjspecific autoantibodies may not affect fre,e T 3 assays but non-specific antibodies which bind both T 4 and T] give anomalous results. The presence of such antibodies may be conveniently confirmed by incubating sera with the radioactive tracers in the absence of the reagent antibody followed by precipitation of antibody-bound radioactivity with poly(ethylene glycol).41,42 Again, no detailed study of prevalence has been made but perhaps a District General Hospital serving a population of 250 000 and using total hormone measurement may expect an incidence of one or two sera a year with antibody titres sufficiently high to produce results at variance with the clinical findings. It is possible that the free hormone assays may be more sensitive to this interference as there are reports of detection in 0·5-1 % of routine samples tested.Y: 44 These antibodies also occur in euthyroid subjects with no history of thyroid disease.v 4h PERIPHERAL RESISTANCE TO THYROID HORMONE A further instance in which diagnostic problems may occur in euthyroid subjects is the extremely rare syndrome of peripheral resistance to thyroid hormones. In theory, this condition may arise either due to a defect in the 5/-deiodination mechanism which converts T 4 to T] in the extrathyroidal tissue, or to an insensitivity to T] at the cellular level. The first might be expected to be manifested by a high concen-tration of free T 4 (the enzyme's substrate) and a correspondingly high total T 4 , and normal free T] and total T]. This has been described.P: 47 In the second type free T] concentration and presumably also free T 4 , total T 4 and total T] would be raised. A very few cases with impaired nuclear binding of T 3 have been described.f" but unfortunately the free hormone levels were not reported, although total T] was raised.
It may be that many of the reported instances of peripheral thyroid hormone resistance are in fact cases of variant binding proteins; this is discussed in greater detail elsewhere.P"
We have, perhaps, dwelt at some length on quite rare cases which interfere with these assays. However, it is such oddities which demand the most time for their solution.
Conclusions
The new assays employing the analogue tracer technique offer a convenient and reliable assessment of free thyroid hormone' concentrations in serum, providing at least comparable and often superior information in one test than was previously only available from two. Problems due to the changes in the concentrations of the binding proteins encountered in the older 'free thyroid hormone indices' do not occur. The choice of the free T4 or the free T] assay depends on the clinical circumstances and the index of diagnostic suspicion. In hyperthyroidism either test provides reliable results; in hypothyroidism neither test has a clear advantage over the total hormone assays, and an additional investigation (TSH) is always required to confirm the diagnosis. There is less interference due to drugs (e.g. phenytoin, aspirin, phenylbutazone) in the free hormone tests than in total hormone assays, but the administration of heparin can artefactually lower free T 4 assay results. In pregnancy, particularly towards the later stages, both free T] and free T 4 may fall, sometimes below the lower limit of the 'normal' range. In nonthyroidal illness a low free T3 is a non-specific finding; free T 4 is more often maintained although may fall too in certain cases. There are a number of well documented, but in practice very rare, cases in which interference in the assays due to the presence of abnormal binding proteins gives misleading results; the total hormone assays are subject to the same interference in many more cases. A single thyroid hormone test which provides 100% diagnosti-cally accurate information does not exist, nor is it likely to.
